Bonum Therapeutics
Samuel Wrenn's work experience includes:
- Currently working as an Associate Scientist II at Bonum Therapeutics since September 2022.
- Worked as an Associate Scientist at Good Therapeutics, Inc. from January 2022 to September 2022.
- Served as a Research Scientist at the Institute for Protein Design, University of Washington from September 2018 to January 2022.
- Participated in the Medical University of South Carolina's Student Undergraduate Research Program (SURP) in 2016, working as a Student Researcher in Dr. Je-Hyun Yoon's laboratory and co-writing a review article on miRNA and siRNA.
- Worked as a Stockroom Assistant at Lawrence University from September 2015 to June 2016, assisting the Stockroom Manager in documenting safety expectations, organizing laboratories, and managing hazardous chemicals.
- Interned at Regulatory Compliance Associates Inc. in June 2015, gaining experience in regulatory compliance.
- Served as an Assistant Lab Technician at the Medical College of Wisconsin from 2012 to 2014.
Samuel Wrenn attended Lawrence University from 2013 to 2017, where they studied Biochemistry & Mathematics. Prior to that, they attended the University School of Milwaukee from 2009 to 2013. Unfortunately, no degree information or specific field of study is provided for either institution.
Bonum Therapeutics
Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.